Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program

Why did the Fed hold rates amid tariff uncertainty? How will US-China trade talks impact markets? What caused WeightWatchers to file for bankruptcy? Why is Newark Airport experiencing flight disruptions? How are Trump tariffs affecting US manufacturers? What explains Netflix's latest homepage redesign? Why did CrowdStrike announce job cuts? How is Disney thriving despite economic concerns? What led to Ford raising prices on Mexico-made cars?

Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program

benzinga.com/general/biotech/25/05/45249094/exclusive-alzamend-neuro-partners-with-qmenta-to-advance-ai-powered-imaging-for-is-phase-2-trial-

Alzamend Neuro, Inc. (NASDAQ:ALZN) on Wednesday announced its partnership with Mint Labs Inc. d/b/a QMENTA, a medical imaging artificial intelligence company, to support its five upcoming Phase 2 trials of AL001 at Massachusetts General Hospital.
QMENTA's cloud-based platform will manage…

This story appeared on benzinga.com, 2025-05-07 11:31:26.